NCT07464925
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07464925
Title A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tetragon Biosciences Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center NOT_YET_RECRUITING Tampa Florida 33612 United States Details
Northwestern Medicine NOT_YET_RECRUITING Chicago Illinois 60611 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field